Study Stopped
No funding to start project.
Zero Ischemia Laparoscopic Partial Nephrectomy
ZILPAREMZ
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Laparoscopic partial nephrectomy (LPN) is often reserved for patients with a small peripheral tumour, in the hands of an experienced surgeon since it demands a high degree of endoscopic skill. Renal vessel clamp for vascular control is a required step during standard LPN. However, this creates a time limiting step for the surgeon and induces renal injury via warm ischemia and reperfusion injury. This novel approach can substantially reduce renal injury during LPN via superselective embolization of level II renal arteries pre-operatively. This technique facilitates the performance of a clamp-less, zero-ischemia LPN, significantly simplifying the procedure by remove time thresholds within which to perform tumor excision. The preliminary results are promising; however, there is a need for further corroboration of their results, in addition to a randomized controlled trial comparing this modified, zero ischemia technique with standard LPN.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2015
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2014
CompletedStudy Start
First participant enrolled
November 1, 2015
CompletedFirst Posted
Study publicly available on registry
December 18, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedJuly 27, 2016
July 1, 2016
5 months
October 10, 2014
July 26, 2016
Conditions
Outcome Measures
Primary Outcomes (3)
Extirpative time
From initial renal tissue breach until completion of bolster placement. Calculated in minutes.
Duration of Surgical Procedure
Warm ischemia time
From renal vessel clamping to unclamping during nephrectomy (only if clamping has occurred). Calculated in minutes.
Duration of Surgical Procedure
Mean estimated blood loss (measured in ml)
From the start of procedure (Nephrectomy), until the end of the procedure.
Duration of Surgical Procedure
Secondary Outcomes (6)
Mean hospital stay
2-10 Days
Blood transfusions
From date of pre-op up to 6 months post-op
Conversion to other type of surgery (i.e. Radical Nephrectomy)
Duration of Surgical Procedure
Identification of other complications (i.e. readmission, arteriovenous malformations)
Up to 24 months post-operatively.
Overall survival rates
Up to 24 months post-operatively.
- +1 more secondary outcomes
Study Arms (1)
Small Renal Mass
NO INTERVENTIONPatient's with a small renal mass will be undergoing embolization prior to laparoscopic partial nephrectomy.
Interventions
Patients will be receiving embolization prior to planned partial nephrectomy.
Patients will be undergoing planned partial nephrectomy post embolization.
Eligibility Criteria
You may qualify if:
- T1a renal cell carcinomas diagnosed by ultrasonography (US), computed tomography (CT) or fine needle aspiration
- tumor size \<4cm in diameter
- predominant exophytic growth
- intraparenchymal depth no greater than 1.5cm, with a minimum distance of 5mm from the urinary collecting system
You may not qualify if:
- predominant endophytic nature (depth \</= 1.5 cm)
- nearness (\<0.5cm) of the tumor to the urinary collecting system
- multiple ipsilateral lesions
- pregnancy
- allergy to intravenous contrast dye
- absolute contraindications to surgical intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Joseph's Healthcare Hamilton - McMaster Institute of Urology
Hamilton, Ontario, L8N4A6, Canada
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, FRCSC
Study Record Dates
First Submitted
October 10, 2014
First Posted
December 18, 2015
Study Start
November 1, 2015
Primary Completion
April 1, 2016
Study Completion
June 1, 2016
Last Updated
July 27, 2016
Record last verified: 2016-07